MetaCurUm aims to raise SEK 100 Million - following founder's prestigious Award
MetaCurUm Biotech AB plans to raise 100 million SEK following founder Maréne Landström being named Sweden's Cancer Researcher of the Year. Their groundbreaking cancer treatment, still in the preclinical phase, aims to halt the TGFβ pathway cancer cells utilize. The Umeå based company is collaborating with international researchers and exploring biomarkers for patient stratification.